TRUALTBSETRUALT BIOENERGY LIMITEDMediumNeutral
Announced Tue, 4 Aug · 13:44 IST

TruAlt Bioenergy Q1 FY27 Earnings: Revenue INR630 Cr, PAT Up 12x YoY

Mgmt Guided Margin ImprovementOrder Pipeline DisclosedInvestor Communications View source PDFExplain this filing

TRUALT · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+5.5%1-day move
₹438.00
prior close
₹442.20
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.1-0.5+5.5+5.8+8.9+9.1+9.5+10.7
Up moveDown movePending
AI summary

TruAlt Bioenergy posted strong Q1 FY27 results. Revenue about INR630 crores led by ethanol at INR626.9 crores. EBITDA grew 129 percent QoQ to INR147.3 crores at 23.5 percent margin. PAT jumped 12 times YoY to INR59.3 crores. Ethanol volume 8.5 crore litres at 60 percent capacity. Management has 44 crore litres of orders for FY27, guides healthy Q2. CBG did INR11 crores revenue at 40-45 percent PAT margin. Plans 72 tons per day new CBG capacity by Q4. SAF business got INR150 crore government funding.

Likely market impact

Strong quarter with 12x PAT growth, healthy 44 cr litre order book, capacity utilization to rise from 60 percent, multi-vertical expansion underway.